Prior Authorization Negatively Impacts Clinical Outcomes

Share this content:
Prior Authorization Negatively Impacts Clinical Outcomes
Prior Authorization Negatively Impacts Clinical Outcomes

MONDAY, March 19, 2018 (HealthDay News) -- The burdens associated with prior authorization (PA) are high and include a negative impact on clinical outcomes, reported by 92 percent of physicians, according to the results of a survey conducted for the American Medical Association (AMA).

The survey examined the experiences of 1,000 practicing physician (40 percent primary care physicians/60 percent specialists) with PA. Twenty-seven questions were administered in December 2017 in the web-based survey.

According to the results of the survey, 64 percent of respondents reported waiting at least one business day for a PA decision from health plans, with 30 percent waiting at least three business days. The PA process delayed care in 92 percent of cases; 78 percent of respondents reported that PA can at least sometimes lead to treatment being abandoned. Overall, 92 percent of respondents reported that PA can have a negative impact on patient clinical outcomes, with a significant negative impact reported by 61 percent. Eighty-four percent of physicians describe the burden associated with PA as high or extremely high for the physicians and staff in practice. Eighty-six percent reported an increase in PA burdens over the past five years.

"The AMA survey illustrates a critical need to help patients have access to safe, timely, and affordable care, while reducing administrative burdens that take resources away from patient care," AMA chair-elect Jack Resneck Jr., M.D., said in a statement.

Press Release
Survey

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »